Cappa M - Search Results

1

Interaction of free fatty acids and arginine on growth hormone secretion in man.

Maccario M, Procopio M, Loche S, Cappa M, Martina V, Camanni F, Ghigo E. Maccario M, et al. Among authors: cappa m. Metabolism. 1994 Feb;43(2):223-6. doi: 10.1016/0026-0495(94)90249-6. Metabolism. 1994. PMID: 8121306 Clinical Trial.

2

Pyridostigmine potentiates growth hormone (GH)-releasing hormone-induced GH release in both men and women.

Arvat E, Cappa M, Casanueva FF, Dieguez C, Ghigo E, Nicolosi M, Valcavi R, Zini M. Arvat E, et al. Among authors: cappa m. J Clin Endocrinol Metab. 1993 Feb;76(2):374-7. doi: 10.1210/jcem.76.2.8432781. J Clin Endocrinol Metab. 1993. PMID: 8432781

3

Reliability of provocative tests to assess growth hormone secretory status. Study in 472 normally growing children.

Ghigo E, Bellone J, Aimaretti G, Bellone S, Loche S, Cappa M, Bartolotta E, Dammacco F, Camanni F. Ghigo E, et al. Among authors: cappa m. J Clin Endocrinol Metab. 1996 Sep;81(9):3323-7. doi: 10.1210/jcem.81.9.8784091. J Clin Endocrinol Metab. 1996. PMID: 8784091

4

Pyridostigmine potentiates L-dopa- but not arginine- and galanin-induced growth hormone secretion in children.

Ghigo E, Bellone J, Imperiale E, Arvat E, Mazza E, Valetto MR, Boffano GM, Cappa M, Loche S, De Sanctis C, et al. Ghigo E, et al. Among authors: cappa m. Neuroendocrinology. 1990 Jul;52(1):42-5. doi: 10.1159/000125536. Neuroendocrinology. 1990. PMID: 1697660

5

Failure of pyridostigmine to increase both basal and GHRH-induced GH secretion in the night.

Ghigo E, Arvat E, Mazza E, Mondardini A, Cappa M, Müller EE, Cammani F. Ghigo E, et al. Among authors: cappa m. Acta Endocrinol (Copenh). 1990 Jan;122(1):37-40. doi: 10.1530/acta.0.1220037. Acta Endocrinol (Copenh). 1990. PMID: 2106188

6

Pyridostigmine counteracts the blunted growth hormone response to growth hormone-releasing hormone of obese children.

Loche S, Pintor C, Cappa M, Ghigo E, Puggioni R, Locatelli V, Müller EE. Loche S, et al. Among authors: cappa m. Acta Endocrinol (Copenh). 1989 May;120(5):624-8. doi: 10.1530/acta.0.1200624. Acta Endocrinol (Copenh). 1989. PMID: 2499149

7

Reduced growth hormone response to growth hormone-releasing hormone in children with simple obesity: evidence for somatomedin-C mediated inhibition.

Loche S, Cappa M, Borrelli P, Faedda A, Crinò A, Cella SG, Corda R, Müller EE, Pintor C. Loche S, et al. Among authors: cappa m. Clin Endocrinol (Oxf). 1987 Aug;27(2):145-53. doi: 10.1111/j.1365-2265.1987.tb01139.x. Clin Endocrinol (Oxf). 1987. PMID: 3117449

8

The effect of hexarelin on growth hormone (GH) secretion in patients with GH deficiency.

Loche S, Cambiaso P, Merola B, Colao A, Faedda A, Imbimbo BP, Deghenghi R, Lombardi G, Cappa M. Loche S, et al. Among authors: cappa m. J Clin Endocrinol Metab. 1995 Sep;80(9):2692-6. doi: 10.1210/jcem.80.9.7673411. J Clin Endocrinol Metab. 1995. PMID: 7673411 Clinical Trial.

9

The growth hormone-releasing activity of hexarelin, a new synthetic hexapeptide, in short normal and obese children and in hypopituitary subjects.

Loche S, Cambiaso P, Carta D, Setzu S, Imbimbo BP, Borrelli P, Pintor C, Cappa M. Loche S, et al. Among authors: cappa m. J Clin Endocrinol Metab. 1995 Feb;80(2):674-8. doi: 10.1210/jcem.80.2.7852535. J Clin Endocrinol Metab. 1995. PMID: 7852535

10

Growth hormone response to oral clonidine test in normal and short children.

Loche S, Cappa M, Ghigo E, Faedda A, Lampis A, Carta D, Pintor C. Loche S, et al. Among authors: cappa m. J Endocrinol Invest. 1993 Dec;16(11):899-902. doi: 10.1007/BF03348953. J Endocrinol Invest. 1993. PMID: 8144867

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

397 results

Search Page

Filters